|
- We make healthy possible - Amneal Pharmaceuticals
Amneal Launches CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules for Treatment of Parkinson’s Disease The most common adverse reactions are nausea and anxiety
- Our Story - Amneal Pharmaceuticals
More than two decades after our founding, Amneal is better positioned than ever to deliver outcomes that meet important medical needs, make quality medicines more accessible and more affordable, and provide solutions for tomorrow’s health challenges
- Generic Products - Amneal Pharmaceuticals
View the catalog of Amneal generic products including the epinephrine auto-injector (authorized generic for Adrenaclick)
- Careers - Amneal Pharmaceuticals
These unauthorized individuals have been engaging with job seekers on various online job-search websites, using the Amneal name and logo to make fraudulent offers of employment in an attempt to solicit up-front fees and obtain personally identifiable information from interested job seekers
- Our Portfolio - Amneal Pharmaceuticals
We are also excited about our work to bring patients more affordable biologic therapy options through our Biosciences, which includes a broad portfolio of institutional injectables as well as Amneal’s growing biosimilars portfolio
- Lets Connect - Amneal Pharmaceuticals
Amneal and Impax Products (877) 835-5472, option 3 DrugSafety@amneal com Administrative Offices: U S Corporate Offices 400 Crossing Boulevard, 3rd Floor Bridgewater, New Jersey 08807 Phone: (908) 947-3120 Fax: (908) 947-3146 Media Inquiries: MediaRelations@amneal com Investor Inquiries: Invest@amneal com Corporate Development Inquiries:
- Amneal Pharmaceuticals, Inc. - News - Press Releases
Amneal Pharmaceuticals LLC issues a Nationwide Recall of Ropivacaine Hydrochloride Injection, USP 500mg 100mL, due to the potential presence of Particulate Matter
- Amneal Pharmaceuticals, Inc. - Investor Relations
Investor Relations Amneal is a global, diversified biopharmaceutical company that provides access to high-quality, affordable, and essential medicines Press Releases Stock Information 12 15 AMRX (NASDAQ)0 201 67% Pricing delayed 20 minutes 11 24 2025 04:00 PM
|
|
|